Lindsey M. Hoffman

4.7k total citations
60 papers, 1.1k citations indexed

About

Lindsey M. Hoffman is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Lindsey M. Hoffman has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 21 papers in Molecular Biology and 19 papers in Neurology. Recurrent topics in Lindsey M. Hoffman's work include Glioma Diagnosis and Treatment (36 papers), Neuroblastoma Research and Treatments (14 papers) and Chromatin Remodeling and Cancer (7 papers). Lindsey M. Hoffman is often cited by papers focused on Glioma Diagnosis and Treatment (36 papers), Neuroblastoma Research and Treatments (14 papers) and Chromatin Remodeling and Cancer (7 papers). Lindsey M. Hoffman collaborates with scholars based in United States, Canada and Germany. Lindsey M. Hoffman's co-authors include Nicholas K. Foreman, Andrew M. Donson, Michael H. Handler, Vladimir Amani, Lia Gore, Andrea M. Griesinger, Todd C. Hankinson, Jean M. Mulcahy Levy, Diane K. Birks and Rajeev Vibhakar and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PEDIATRICS.

In The Last Decade

Lindsey M. Hoffman

55 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lindsey M. Hoffman United States 20 558 432 255 254 186 60 1.1k
Yazmín Odia United States 20 569 1.0× 446 1.0× 205 0.8× 174 0.7× 217 1.2× 89 1.2k
Hilary Blair United States 12 703 1.3× 429 1.0× 169 0.7× 152 0.6× 249 1.3× 17 1.2k
Anu Banerjee United States 16 597 1.1× 282 0.7× 114 0.4× 355 1.4× 152 0.8× 32 956
Pankaj K. Agarwalla United States 18 457 0.8× 368 0.9× 238 0.9× 339 1.3× 133 0.7× 53 1.5k
Katharina Seystahl Switzerland 16 434 0.8× 230 0.5× 192 0.8× 133 0.5× 196 1.1× 40 867
Genevieve Schindler Germany 6 776 1.4× 605 1.4× 231 0.9× 356 1.4× 175 0.9× 8 1.3k
Lynley V. Marshall United Kingdom 17 292 0.5× 459 1.1× 439 1.7× 309 1.2× 164 0.9× 62 1.2k
Ziming Du China 17 234 0.4× 484 1.1× 215 0.8× 163 0.6× 145 0.8× 32 1.0k
Manabu Natsumeda Japan 19 510 0.9× 408 0.9× 148 0.6× 224 0.9× 155 0.8× 74 1.0k
E Madon Italy 19 437 0.8× 321 0.7× 234 0.9× 307 1.2× 249 1.3× 74 1.4k

Countries citing papers authored by Lindsey M. Hoffman

Since Specialization
Citations

This map shows the geographic impact of Lindsey M. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsey M. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsey M. Hoffman more than expected).

Fields of papers citing papers by Lindsey M. Hoffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsey M. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsey M. Hoffman. The network helps show where Lindsey M. Hoffman may publish in the future.

Co-authorship network of co-authors of Lindsey M. Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsey M. Hoffman. A scholar is included among the top collaborators of Lindsey M. Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsey M. Hoffman. Lindsey M. Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almefty, Kaith K., T.Z. Vern-Gross, Lindsey M. Hoffman, et al.. (2024). Atypical Teratoid Rhabdoid Tumor of the Brain in a Young Adult With Down Syndrome: Case Report and Literature Review. Journal of Pediatric Hematology/Oncology. 47(1). e52–e57. 1 indexed citations
2.
Bristol, Ruth E., et al.. (2024). GCT-26. INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMOR WITH MALIGNANT TRANSFORMATION TO EMBRYONAL RHABDOMYSARCOMA. Neuro-Oncology. 26(Supplement_4). 0–0.
3.
Ronsley, Rebecca, Bonnie Cole, Tyler G. Ketterl, et al.. (2024). Pediatric Central Nervous System Embryonal Tumors: Presentation, Diagnosis, Therapeutic Strategies, and Survivorship—A Review. Pediatric Neurology. 161. 237–246. 4 indexed citations
4.
Dorris, Kathleen, Molly Hemenway, Jean M. Mulcahy Levy, et al.. (2024). CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL TRIAL OF INTRAVENOUS TOCILIZUMAB FOR ADAMANTINOMATOUS CRANIOPHARYNGIOMA. Neuro-Oncology. 26(Supplement_4). 0–0. 1 indexed citations
5.
Tilburg, Cornelis M. van, Lindsay Kilburn, Erin Crotty, et al.. (2023). LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.. Journal of Clinical Oncology. 41(16_suppl). TPS10067–TPS10067. 4 indexed citations
6.
Lazow, Margot, Adam Lane, Maryam Fouladi, et al.. (2022). Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro-Oncology. 24(9). 1598–1608. 6 indexed citations
8.
Fuller, Christine, Olivia Campagne, Tong Lin, et al.. (2021). A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. Clinical Cancer Research. 27(9). 2442–2451. 17 indexed citations
9.
Hanson, Derek, Lindsey M. Hoffman, Liliana Goumnerova, et al.. (2020). A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettes. Neuro-Oncology Advances. 2(1). vdaa120–vdaa120. 14 indexed citations
10.
Cash, Thomas F., Dolly Aguilera, Margaret E. Macy, et al.. (2019). Abstract C002: Phase 1 study of abemaciclib in children with recurrent and refractory solid tumors including malignant brain tumors. Molecular Cancer Therapeutics. 18(12_Supplement). C002–C002.
11.
Donson, Andrew M., Vladimir Amani, Andrea M. Griesinger, et al.. (2018). Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma. Molecular Cancer Therapeutics. 17(9). 1984–1994. 23 indexed citations
12.
Linzey, Joseph R., Bernard L. Marini, Amy L. Pasternak, et al.. (2017). Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology. Journal of Neuro-Oncology. 137(1). 155–169. 10 indexed citations
13.
Hoffman, Lindsey M., Maryam Fouladi, James M. Olson, et al.. (2015). Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Child s Nervous System. 31(8). 1283–1289. 41 indexed citations
14.
Griesinger, Andrea M., Andrew M. Donson, Jean M. Mulcahy Levy, et al.. (2015). Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma. Cancer Immunology Research. 3(10). 1165–1174. 56 indexed citations
15.
Hoffman, Lindsey M., Ralph Salloum, & Maryam Fouladi. (2015). Molecular Biology of Pediatric Brain Tumors and Impact on Novel Therapies. Current Neurology and Neuroscience Reports. 15(4). 10–10. 4 indexed citations
17.
Dudley, Roy, Michelle Torok, Jean M. Mulcahy Levy, et al.. (2015). Pediatric Low-Grade Ganglioglioma. Neurosurgery. 76(3). 313–320. 64 indexed citations
19.
Hoffman, Lindsey M., et al.. (2013). Pulmonary Presentation of Relapsed Acute Myeloid Leukemia. Journal of Pediatric Hematology/Oncology. 36(3). 228–230. 5 indexed citations
20.
Hoffman, Lindsey M., et al.. (2012). Human Papillomavirus Vaccination in Female Pediatric Cancer Survivors. Journal of Pediatric and Adolescent Gynecology. 25(5). 305–307. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026